Aquestive Therapeutics, Inc. (AQST) › Shareholders' EquityAquestive Therapeutics, Inc. (AQST) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -$57.20M2017: -$26.50M2018: $10.08M2019: -$6.12M2020: -$48.50M2021: -$82.13M2022: -$118.55M2023: -$106.49M2024: -$60.16M2025: -$33.66M-$33.66M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$33.66M+44.0%2024-$60.16M+43.5%2023-$106.49M+10.2%2022-$118.55M-44.3%2021-$82.13M-69.4%2020-$48.50M-692.2%2019-$6.12M-160.7%2018$10.08M+138.0%2017-$26.50M+53.7%2016-$57.20M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share